osudhkosh
New

৳ 1/unit

Pack: ৳ 1

TabletTablet
Save to my medicines
Alert me on price drop

At a glance

Almitrine Bismesylate + Raubasine is a combination medicine that increases oxygen supply to the brain and neurosensory tissues. It is used to reduce neurological damage and accelerate recovery after stroke, treat minor age-related neurological disorders, and manage circulation-related visual and inner ear disorders.

Indications

Cerebrovascular insufficiency; reduction of neurological damage and acceleration of recovery after stroke; minor age-related neurological disorders; circulation-related visual disorders; circulation-related vestibular and auditory disorders (tinnitus, dizziness, vertigo).

Pharmacology

Almitrine stimulates carotid body chemoreceptors to improve alveolar-capillary gas exchange and increase arterial oxygen pressure (PaO2) and oxygen saturation (SaO2). Raubasine is a vasodilator that improves cerebral blood flow through post-synaptic blocking effects. Together, these mechanisms increase oxygen supply to the brain and neurosensory tissues, improve mitochondrial function, and shift cellular metabolism toward aerobic pathways.

Dosage

Adults:

  • 1 tablet twice daily (morning and evening) – maximum 2 tablets per day
  • Several hours interval between the two doses
  • May be taken with or without food
Side effects

Common side effects:

  • Weight loss (with long-term use)
  • Nausea, heavy or burning sensation in stomach, gastrointestinal disorders
  • Diarrhea or constipation
  • Insomnia, drowsiness, restlessness, anxiety
  • Dizziness, palpitations
  • Peripheral neuropathy (numbness, tingling, formication in lower limbs) – rare with long-term use
Use in pregnancy

Safety during pregnancy has not been established; use during pregnancy is not recommended. Use only if clearly needed with medical advice.

Pregnancy Category: C — always consult a doctor before taking during pregnancy.

Precautions & warnings
  • Discontinue if numbness, tingling, or formication occurs in the lower limbs
  • Discontinue if weight loss exceeds 5%
  • Do not exceed the recommended dose
  • Caution while driving (may cause drowsiness and dizziness)
  • Caution in patients with lactose intolerance, galactosemia, or glucose-galactose malabsorption
Overdose effects

Overdose symptoms: tachycardia, arterial hypotension, polypnea, and respiratory alkalosis. Seek immediate medical attention if overdose is suspected.

Storage conditions

Store in a cool and dry place, protected from light and moisture. Keep out of reach of children.

Almitrine Bismesylate + Raubasine — see the full informationPharmacology, precautions, pregnancy, overdose and the rest on the generic page
⚠️ This information is for educational purposes only — not a substitute for medical advice. Consult a registered physician before taking any medicine.